Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 23 of 78 for:    vismodegib

A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02593760
Recruitment Status : Completed
First Posted : November 2, 2015
Last Update Posted : May 10, 2018
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 29, 2017
Actual Study Completion Date : July 12, 2017